Brian Bonnell - Mar 6, 2023 Form 4 Insider Report for ICU MEDICAL INC/DE (ICUI)

Role: Chief Financial Officer
Signature: By: Paula Darbyshire, Attorney-in-fact For: Brian M. Bonnell
Stock symbol: ICUI
Transactions as of: Mar 6, 2023
Transactions value $: -$1,233,384
Form type: 4
Date filed: 3/8/2023, 03:52 PM
Previous filing: Mar 8, 2022
Next filing: May 18, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ICUI	Common Stock	Options Exercise	$0	+1.55K	+28.32%	$0.00	7.03K	Mar 6, 2023	Direct	F1
transaction	ICUI	Common Stock	Tax liability	-$132K	-816	-11.61%	$161.25	6.21K	Mar 6, 2023	Direct
transaction	ICUI	Common Stock	Options Exercise	$0	+8.75K	+140.78%	$0.00	15K	Mar 6, 2023	Direct
transaction	ICUI	Common Stock	Tax liability	-$742K	-4.6K	-30.78%	$161.25	10.4K	Mar 6, 2023	Direct
transaction	ICUI	Common Stock	Options Exercise	$0	+2.15K	+20.72%	$0.00	12.5K	Mar 7, 2023	Direct	F1
transaction	ICUI	Common Stock	Tax liability	-$178K	-1.13K	-9.03%	$157.47	11.4K	Mar 7, 2023	Direct
transaction	ICUI	Common Stock	Options Exercise	$0	+2.21K	+19.43%	$0.00	13.6K	Mar 8, 2023	Direct	F1
transaction	ICUI	Common Stock	Tax liability	-$182K	-1.16K	-8.57%	$156.17	12.4K	Mar 8, 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ICUI	Common Stock	Options Exercise	$0	-1.55K	-100%	$0.00^*	0	Mar 6, 2023	Common Stock	1.55K	$0.00	Direct	F1, F2, F3, F4
transaction	ICUI	Common Stock	Options Exercise	$0	-2.21K	-49.99%	$0.00	2.21K	Mar 8, 2023	Common Stock	2.21K	$0.00	Direct	F1, F2, F3, F4
transaction	ICUI	Common Stock	Options Exercise	$0	-2.15K	-33.33%	$0.00	4.29K	Mar 7, 2023	Common Stock	2.15K	$0.00	Direct	F1, F2, F3, F4
transaction	ICUI	Performance Shares	Options Exercise	$0	-8.75K	-100%	$0.00^*	0	Mar 6, 2023	Common Stock	8.75K		Direct	F5, F6, F7

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These securities are Restricted Stock Units.
F2	There is neither a purchase price nor an exercise price for the Restricted Stock Units.
F3	One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.
F4	These are restricted stock units that fully vest 3 years from the grant date.
F5	These Securities are Performance-based Restricted Stock Units (PRSU).
F6	There is neither a purchase price nor an exercise price for the PRSUs.
F7	These PRSUs were granted on March 6, 2020 and were subject to the satisfaction of both performance-based and time-based criteria. These PRSUs had a 3-year performance period and cliff-vested on the third anniversary of the grant date.